ADCETRIS (brentuximab vedotin) is indicated for treatment of patients with Hodgkin lymphoma (HL) after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates. ADCETRIS (brentuximab vedotin) for injection, for intravenous use. Initial U.S. approval: 2011. ADCETRIS (brentuximab vedotin) For Injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

What is Adcetris used for?

ADCETRIS is indicated for treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen.

Please contact +91 9811747774 for ADCETRIS (brentuximab vedotin) For Injection cost in India

Where can I buy Adcetris (brentuximab vedotin)?

Indian Pharma Network, your facilitator for Named Patient Medicines helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Adcetris (brentuximab vedotin) on prescription and Import License in Patient's Name only.

ADCETRIS (brentuximab vedotin)

Get In Touch

Adcetris (brentuximab vedotin) Can be made available

ADCETRIS can be made available at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

For injection: 50 mg lyophilized powder in a single-use vial (D).

ReadMore

FDA News Release

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.
Dated: March 20, 2018

ReadMore